|
Pharmacological Group: Antibacterials, Active Principle: Amicacin Sulfate, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 250, Unit: Mg / Ml, Volume: 2Ml, Presentation: Ampoule, Accessory: Not Applicable, Pharmacological Group: Hydroelectrolic Solutions And Balancing Balancing, Active Principle: Potassium, Concentration / Dosage: 2, Unit: Meq / Ml, Volume: 10 Ml, Accessory: N / A, Form Supply: Unit, Active Principle: Gentamycin Sulfate, Concentration / Dosage: 40, Pharmacological Group: Antigolars, Antagonists And Plaquetarians, Active Principle: Sodic Heparin, Concentration / Dosage: 5000 Ui, Volume: 0, 25Ml, Unit: Ui/Ml, Volume: 5 Ml, Presentation: Ampolo Vial, 20/03/2025, Pharmacological Group: Plasma Plasma Expanders, Active Principle: Hydroxyetilic Starch, Concentration/Dosage: 0, 06, Unit: G/Ml, Volume: 500Ml: Pharmacological: Antibacterial, Active Principle: Levofloxacin, Concentration / Dosage: 5Mg / Ml, Volume: 100 Ml, Bag, Pharmacological Group: Local Anesthesic, Active Principle: Ropivacaine Hydrochloride, Concentration / Dosage: 1, Unit: %, Volume: 20 Ml, Active Principle: Sodium Chloride + Chloride + Chloride Potassium + Sodio Citrate + Glucose, Pharmaceutical Form: Po, Concentration / Dosage: 3, 5 + 1, 5 + 2, 9 + 20, Unit: G, Volume: Not Applied, Presentation: Envelope 27, 9G, Sodic Varfarina, Pharmaceutical Form: Compressed, Concentration / Dosage: 5, Unit: Mg, Introduction:
|
